Evidence map›Paper›PMID 29974297›Full record

ArticleHuman genetics2019

Expanding the phenotype of the X-linked BCOR microphthalmia syndromes.

Nicola Ragge, Bertrand Isidor, Pierre Bitoun, Sylvie Odent, Irina Giurgea, Benjamin Cogné, Wallid Deb, Marie Vincent, Jessica Le Gall, Jenny Morton and 19 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A novel frameshift mutation in theInternational journal of ophthalmology · 2025
    Article
  6. Article
  7. Article
  8. Oculo-facio-cardio-dental (OFCD) syndrome: a case report.Journal of medical case reports · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Tooth number abnormality: from bench to bedside.International journal of oral science · 2023
    Review
  14. Article
  15. Mutations inScience advances · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 15 institutions in 7 countries.

Nicola RaggeDepartment of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK. nragge@brookes.ac.uk.ORCID http://orcid.org/0000-0002-6122-4521
Bertrand IsidorService de génétique médicale, Hôtel-Dieu, CHU de Nantes, Nantes, France.
Pierre BitounSIDVA 91, Ophthalmic Genetics, 1 rue de la Cour de, 91260, Juvisy s/orge, France.
Sylvie OdentService de Génétique Clinique, Centre de référence CLAD-Ouest, Université Rennes 1, UMR 6290 CNRS IGDR, CHU Rennes, Rennes, France.
Irina GiurgeaU.F. de Génétique moléculaire, Hôpital Armand Trousseau, Assistance Publique, Hôpitaux de Paris, 75012, Paris, France.
Benjamin CognéService de génétique médicale, Hôtel-Dieu, CHU de Nantes, Nantes, France.
Wallid DebService de génétique médicale, Hôtel-Dieu, CHU de Nantes, Nantes, France.
Marie VincentService de génétique médicale, Hôtel-Dieu, CHU de Nantes, Nantes, France.
Jessica Le GallService de génétique médicale, Hôtel-Dieu, CHU de Nantes, Nantes, France.
Jenny MortonWest Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK.
Derek LimWest Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK.
DDD Study
Guylène Le MeurService d'ophtalmologie, Hôtel Dieu, CHU de Nantes, Nantes, France.
Celia Zazo SecoUDEAR, UMR 1056 Inserm, Université de Toulouse, Toulouse, France.
Dimitra ZafeiropoulouDepartment of Human Genetics, Radboud University Medical Centre, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands.
Dorine BaxDepartment of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.
Petra ZwijnenburgDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Anara ArtecheDepartment of Genetics, Health Research Institute-Jiménez Díaz Foundation, University Hospital (IIS-FJD-UAM), Madrid, Spain.
Saoud Tahsin SwafiriDepartment of Genetics, Health Research Institute-Jiménez Díaz Foundation, University Hospital (IIS-FJD-UAM), Madrid, Spain.
Ruth CleaverSouth West Thames Regional Genetics Service, St. George's Healthcare NHS Trust, London, UK.
Meriel McEntagartSouth West Thames Regional Genetics Service, St. George's Healthcare NHS Trust, London, UK.
Usha KiniOxford Centre for Genomic Medicine, Oxford, UK.
William NewmanManchester Royal Eye Hospital, Manchester, UK.
Carmen AyusoDepartment of Genetics, Health Research Institute-Jiménez Díaz Foundation, University Hospital (IIS-FJD-UAM), Madrid, Spain.
Marta CortonDepartment of Genetics, Health Research Institute-Jiménez Díaz Foundation, University Hospital (IIS-FJD-UAM), Madrid, Spain.
Yvan HerengerService de Génétique Médicale, CHU de Tours, Tours, France.
Médéric JeanneService de Génétique Médicale, CHU de Tours, Tours, France.
Patrick CalvasUDEAR, UMR 1056 Inserm, Université de Toulouse, Toulouse, France.
Nicolas ChassaingUDEAR, UMR 1056 Inserm, Université de Toulouse, Toulouse, France.
Centre Hospitalier Universitaire de Nantes · FROxford Brookes University · GBSt George’s University Hospitals NHS Foundation Trust · GBBirmingham Women’s and Children’s NHS Foundation Trust · GBCentre Hospitalier Universitaire de Tours · FRHospital Universitario Fundación Jiménez Díaz · ESInserm · FRInstituto de Salud Carlos III · ESManchester Royal Eye Hospital · GBCentre Hospitalier de Beauvais · FRCentre National de la Recherche Scientifique · FRDélégation Paris 5 · FRGénétique Médicale & Génomique Fonctionelle · FRHotel Dieu Hospital · CARadboud University Nijmegen · NL

Funding

Clinical Research Hospital Program from the French Ministry of Health (PHRC 09 109 01)Health Innovation Challenge Fund HICF-1009-003Spanish Institute of Health Carlos III CP12/03256Spanish Ministry of Economy and Competitiveness SAF2013-46943-RWellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute WT098051
6 · The paper itself

Abstract

Two distinct syndromes arise from pathogenic variants in the X-linked gene BCOR (BCL-6 corepressor): oculofaciocardiodental (OFCD) syndrome, which affects females, and a severe microphthalmia ('Lenz'-type) syndrome affecting males. OFCD is an X-linked dominant syndrome caused by a variety of BCOR null mutations. As it manifests only in females, it is presumed to be lethal in males. The severe male X-linked recessive microphthalmia syndrome ('Lenz') usually includes developmental delay in addition to the eye findings and is caused by hypomorphic BCOR variants, mainly by a specific missense variant c.254C > T, p.(Pro85Leu). Here, we detail 16 new cases (11 females with 4 additional, genetically confirmed, affected female relatives; 5 male cases each with unaffected carrier mothers). We describe new variants and broaden the phenotypic description for OFCD to include neuropathy, muscle hypotonia, pituitary underdevelopment, brain atrophy, lipoma and the first description of childhood lymphoma in an OFCD case. Our male X-linked recessive cases show significant new phenotypes: developmental delay (without eye anomalies) in two affected half-brothers with a novel BCOR variant, and one male with high myopia, megalophthalmos, posterior embryotoxon, developmental delay, and heart and bony anomalies with a previously undescribed BCOR splice site variant. Our female OFCD cases and their affected female relatives showed variable features, but consistently had early onset cataracts. We show that a mosaic carrier mother manifested early cataract and dental anomalies. All female carriers of the male X-linked recessive cases for whom genetic confirmation was available showed skewed X-inactivation and were unaffected. In view of the extended phenotype, we suggest a new term of X-linked BCOR-related syndrome.

Indexed as

Abnormalities, MultipleAdolescentAdultCataractChild, PreschoolChromosomes, Human, XEye AbnormalitiesFemaleGenes, X-LinkedGenetic VariationHeart Septal DefectsHeterozygoteHumansInfantMaleMicrophthalmosBCOR protein, humanProto-Oncogene ProteinsRepressor Proteins

Identifiers

PMID29974297
OpenAlexW2811096374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.